All posts tagged
British Biotech’s Gene Therapy for Rare ‘Bubble Baby’ Disease gets Fast-Tracked by the FDA
French Biotech and Canadian University to treat Rare Disease with Red Blood Cells
Meet the CEO of Minoryx, the Spanish Biotech Fighting Rare Disease
German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases
New Dutch Biotech gets Funding to Find Genetic Off Switches
UPDATE: UK Cannabis Biotech ready for a Blockbuster in Rare Epilepsy
What Happens when the Immune System Attacks Life-Saving Drugs?
French Gene Therapy Biotech Raises a Huge €37.5M in Series A
Goodbye Glybera! The World’s First Gene Therapy will be Withdrawn
More “FDA Love” for Cannabis Company with Orphan Drug Designation
Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?
A Potential First Treatment for a Rare Genetic Disease clears Phase I
Labiotech UG, All Rights Reserved -
Send this to friend